| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Net sales | ||||||
1,292,900 | 1,133,600 | 972,400 | 908,300 | 958,300 | 1,035,500 | |
Cost of sales | ||||||
810,900 | 716,800 | 643,400 | 633,900 | 682,900 | 717,000 | |
Gross profit | ||||||
482,000 | 416,800 | 329,000 | 274,400 | 275,400 | 318,500 | |
Selling, general and administrative expenses | ||||||
163,100 | 132,400 | 106,400 | 96,400 | 92,700 | 107,700 | |
Research and technical expenses | ||||||
19,700 | 21,500 | 19,800 | 17,600 | 17,400 | - | |
Separation costs | ||||||
0 | 0 | 900 | 17,500 | 17,200 | 400 | |
Restructuring and other (income) charges, net | ||||||
1,800 | -500 | 3,700 | 41,200 | -7,500 | -5,600 | |
Acquisition-related costs | ||||||
26,900 | 10,800 | 7,100 | 0 | 0 | - | |
Other (income) expense, net | ||||||
4,300 | -1,000 | -500 | 3,200 | 1,000 | 2,500 | |
Interest expense | ||||||
54,600 | 33,200 | 18,100 | 19,300 | 20,100 | 16,400 | |
Interest income | ||||||
7,700 | 3,400 | 2,300 | 1,400 | 0 | 0 | |
Income (loss) before income taxes | ||||||
227,900 | 221,800 | 174,800 | 87,000 | 136,500 | 202,100 | |
Provision (benefit) for income taxes | ||||||
44,200 | 40,000 | 29,600 | 42,600 | 52,200 | 69,500 | |
Net income (loss) | ||||||
183,700 | 181,800 | 145,200 | 44,400 | 84,300 | 132,600 | |
Less: Net income (loss) attributable to noncontrolling interests | ||||||
0 | 12,700 | 18,700 | 9,200 | 4,600 | 3,600 | |
Net income (loss) attributable to Ingevity stockholders | ||||||
183,700 | 169,100 | 126,500 | 35,200 | 79,700 | 129,000 | |
Per share data | ||||||
Basic earnings (loss) per share (usd per share) | ||||||
4.39 | 4.02 | 3.00 | 0.83 | 1.89 | 3.06 | |
Diluted earnings (loss) per share (usd per share) | ||||||
4.35 | 3.97 | 2.97 | 0.83 | 1.89 | 3.06 | |